Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial

Bengt C. Fellström^*, Jonathan Barratt, Heather Cook, Rosanna Coppo, John Feehally, Johan W. de Fijter, Jürgen Floege, Gerd Hetzel, Alan G. Jardine, Francesco Locatelli, Bart D. Maes, Alex Mercer, Fernanda Ortiz, Manuel Praga, Søren S. Sørensen, Vladimir Tesar, Lucia Del Vecchio, NEFIGAN Trial Investigators

^*Corresponding author af dette arbejde